Kazakhstan’s cancer care landscape is undergoing a significant transformation. With rising detection rates, expanded screening programs, modern diagnostic tools, and increased government investment, the need for consistent access to high-quality oncology medicines has never been greater. In this environment, a reliable cancer medicine exporter such as Aliyan Pharmaceuticals plays a pivotal role in bridging gaps